Guangzhou, China

Xiaoqian Xue

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xiaoqian Xue: Innovator in Medicinal Chemistry

Introduction

Xiaoqian Xue is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 2 patents, Xue's work focuses on developing compounds that have the potential to treat various diseases.

Latest Patents

Xue's latest patents include two notable inventions. The first patent is for a benzidine compound and its application. This compound is designed to be used in the preparation of drugs for the treatment or prevention of RORγ-regulated diseases. Additionally, it has applications in treating inflammation, immune diseases, cancer, and neurological disorders. The second patent involves a 2-oxo-1,2-dihydrobenzo[cd]indole compound. This compound is effective in inhibiting the BET bromodomain receptor and can be utilized in medicines for treating cancers, cell proliferative disorders, inflammatory diseases, autoimmune disorders, sepsis, and viral infections.

Career Highlights

Xiaoqian Xue has worked with notable organizations such as Guangzhou Imd Therapeutics Co., Ltd. and the Chinese Academy of Sciences. His experience in these institutions has allowed him to advance his research and contribute to the field of medicinal chemistry.

Collaborations

Xue has collaborated with several professionals in his field, including Yong Xu and Yan Zhang. These collaborations have further enriched his research and development efforts.

Conclusion

Xiaoqian Xue is a distinguished inventor whose work in medicinal chemistry has the potential to impact the treatment of various diseases significantly. His innovative patents reflect his dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…